OXALIPLATIN MEDAC 50 MG Israel - English - Ministry of Health

oxaliplatin medac 50 mg

tzamal bio-pharma ltd - oxaliplatin - powder for solution for infusion - oxaliplatin 50 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke‘s c) colon cancer after complete resection of primary tumor. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).

OXALIPLATIN MEDAC 100 MG Israel - English - Ministry of Health

oxaliplatin medac 100 mg

tzamal bio-pharma ltd - oxaliplatin - powder for solution for infusion - oxaliplatin 100 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke‘s c) colon cancer after complete resection of primary tumor. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).

OXALIPLATIN MEDAC 150 MG Israel - English - Ministry of Health

oxaliplatin medac 150 mg

tzamal bio-pharma ltd - oxaliplatin - powder for solution for infusion - oxaliplatin 150 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke‘s c) colon cancer after complete resection of primary tumor. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).

Bleomedac 15,000 IU/ vial, powder for solution for injection Malta - English - Medicines Authority

bleomedac 15,000 iu/ vial, powder for solution for injection

medac gesellschaft fur klinische spezialpräparate mbh theaterstr. 6 22880 wedel, germany - powder for solution for injection - bleomycin sulfate 15,000 iu - antineoplastic agents

Gliolan European Union - English - EMA (European Medicines Agency)

gliolan

photonamic gmbh & co. kg - 5-aminolevulinic acid hydrochloride - glioma - antineoplastic agents - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (world health organization grade iii and iv).

Medicine administration kit, percutaneous, medicated, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, medicated, single-use

link medical products pty ltd t/a link pharmaceuticals - 45156 - medicine administration kit, percutaneous, medicated, single-use - a collection of one device and one registered product, used to administer a medication by injection. it contains a registered product in a prefilled syringe with a fixed needle containing a single dose of the medication, and a skin cleaning wipe. this is a single-use device.

UROKINASE MEDAC 10000 IU Israel - English - Ministry of Health

urokinase medac 10000 iu

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 10000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

UROKINASE MEDAC 50000 IU Israel - English - Ministry of Health

urokinase medac 50000 iu

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 50000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

UROKINASE MEDAC 100000 IU Israel - English - Ministry of Health

urokinase medac 100000 iu

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 100,000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

UROKINASE MEDAC 250000 IU Israel - English - Ministry of Health

urokinase medac 250000 iu

tzamal bio-pharma ltd - urokinase - powder for solution for injection - urokinase 250000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.